Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3203-3208, June 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dupressoir, T.
Right arrow Articles by Rommelaere, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dupressoir, T.
Right arrow Articles by Rommelaere, J.

Inhibition by Parvovirus H-1 of the Formation of Tumors in Nude Mice and Colonies in Vitro by Transformed Human Mammary Epithelial Cells1

Thierry Dupressoir2, Jean-Marc Vanacker, Jan J. Cornelis, Nadine Duponchel and Jean Rommelaere

Laboratory of Molecular Oncology, Inserm U186, and CNRS URA 0156, Institut Pasteur de Lille, F59019 Lille Cedex, France [T. D., J-M. V., J. J. C., N. D., J. R.], and Laboratory of Biophysics and Radiobiology, Université Libre de Bruxelles, B1640 Rhode-St. Genèse, Belgium [J. J. C., J. R.]

The formation of tumors in adult nude mice from transformed human mammary epithelial cells was drastically inhibited (>80%) both after coinjection of tumoral cells and virus or after a single s.c. injection of parvovirus H-1 at the site of cell implantation prior to tumor formation. Moreover, when injected i.v. in animals bearing preformed tumors, H-1 virus was able to slow down and even in some cases to revert neoplastic growth. Thus, H-1 virus achieved the suppression of implanted tumors of human origin under conditions where the immune antitumor mechanisms of the recipient animals were dramatically impaired. Viral infection was not accompanied by detectable deleterious side effects. Imprints of H-1 virus DNA were found in one residual tumor. Normal human mammary epithelial cells were also compared with homologous transformed cells, either derived from tumors (three lines) or containing simian virus 40 (one line), for their susceptibility to the lytic replication of H-1 virus in vitro. Transformed cell lines were more sensitive to virus-induced killing than secondary cultures of normal cells. Moreover, the former had much greater abilities than the latter to amplify viral DNA and to express the viral nonstructural protein NS-1. Altogether, these results are compatible with the idea that the oncosuppressive activity exerted by H-1 virus may be mediated, at least in part, by virus replication in developing tumors.

1 This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Association pour la Recherche sur le Cancer, Institut Pasteur de Lille (France), the Ministère de la Politique Scientifique, Caisse Générale d'Epargne et de Retraite, and Fonds National de la Recherche Scientifique (Belgium). T. D. and J-M. V. are supported by the Institut Pasteur de Lille and the Ministère de l'Industrie et de la Recherche, respectively.

2 To whom requests for reprints should be addressed.

Received 11/14/88. Revised 3/13/89. Accepted 3/21/89.




This article has been cited by other articles:


Home page
J. Virol.Home page
L. Daeffler, R. Horlein, J. Rommelaere, and J. P. F. Nuesch
Modulation of Minute Virus of Mice Cytotoxic Activities through Site-Directed Mutagenesis within the NS Coding Region
J. Virol., December 1, 2003; 77(23): 12466 - 12478.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Malerba, L. Daeffler, J. Rommelaere, and R. D. Iggo
Replicating Parvoviruses That Target Colon Cancer Cells
J. Virol., June 15, 2003; 77(12): 6683 - 6691.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Wrzesinski, L. Tesfay, N. Salome, J.-C. Jauniaux, J. Rommelaere, J. Cornelis, and C. Dinsart
Chimeric and Pseudotyped Parvoviruses Minimize the Contamination of Recombinant Stocks with Replication-Competent Viruses and Identify a DNA Sequence That Restricts Parvovirus H-1 in Mouse Cells
J. Virol., March 15, 2003; 77(6): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-P. Rubio, S. Guerra, and J. M. Almendral
Genome Replication and Postencapsidation Functions Mapping to the Nonstructural Gene Restrict the Host Range of a Murine Parvovirus in Human Cells
J. Virol., December 1, 2001; 75(23): 11573 - 11582.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.